# GEHC (GE Healthcare Technologies Inc.) - SEC EDGAR Financial Statements

> GE Healthcare Technologies Inc. reported $21.64B in revenue and net income of $2.15B for the trailing twelve months ended September 30, 2026 (up 7.2% year over year), with a 39.9% gross margin and a 13.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/GEHC
- Markdown: https://convexityos.com/fundamentals/GEHC.md
- SEC CIK: 0001932393
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:04 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001932393&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $21.64B | +7.2% YoY |
| Operating Income | TTM | $2.89B | 13.3% margin |
| Net Income | TTM | $2.15B | 10.0% net margin |
| Diluted EPS | TTM | $4.75 | Split-adjusted |
| Free Cash Flow | TTM | $1.50B | 7.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $2.83B | Total debt: $10.41B |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $20.62B | $19.67B | $19.55B | $18.34B | $17.59B |
| **Gross Profit** | $8.25B | $8.21B | $7.92B | $7.18B | $7.17B |
| Research & Development | $1.26B | $1.31B | $1.21B | $1.03B | $816.0M |
| Selling, General & Admin | $4.22B | $4.27B | $4.28B | $3.63B | $3.56B |
| Total Operating Expenses | $5.49B | $5.58B | $5.49B | $4.66B | $4.38B |
| **Operating Income** | $2.76B | $2.62B | $2.44B | $2.52B | $2.79B |
| **EBITDA** | $3.34B | $3.21B | $3.04B | $3.15B | $3.42B |
| Interest Expense | $440.0M | $504.0M | $542.0M | $77.00M | $40.00M |
| Income Before Tax | $2.77B | $2.58B | $2.36B | $2.51B | $2.88B |
| Income Tax Expense | $614.0M | $531.0M | $743.0M | $563.0M | $600.0M |
| **Net Income** | $2.08B | $1.99B | $1.57B | $1.92B | $2.25B |
| Basic EPS | $4.56 | $4.37 | $3.05 | $4.22 | $4.95 |
| **Diluted EPS** | $4.55 | $4.34 | $3.03 | $4.22 | $4.95 |
| Basic Shares Outstanding | 456.0M | 456.0M | 455.0M | 454.0M | 454.0M |
| Diluted Shares Outstanding | 458.0M | 459.0M | 458.0M | 454.0M | 454.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $5.51B | $5.29B | $5.13B | $5.70B | $5.14B | $5.01B | $4.78B | $5.32B |
| **Gross Profit** | $2.22B | $2.18B | $1.98B | $2.26B | $1.99B | $1.99B | $2.01B | $2.27B |
| Research & Development | $320.0M | $323.0M | $345.0M | $323.0M | $292.0M | $302.0M | $344.0M | $344.0M |
| Selling, General & Admin | $1.10B | $1.12B | $1.12B | $1.11B | $1.04B | $1.03B | $1.04B | $1.13B |
| Total Operating Expenses | $1.42B | $1.44B | $1.46B | $1.43B | $1.34B | $1.33B | $1.38B | $1.47B |
| **Operating Income** | $805.0M | $739.0M | $515.0M | $827.0M | $653.0M | $654.0M | $629.0M | $801.0M |
| **EBITDA** | $968.0M | $899.0M | $668.0M | $973.0M | $802.0M | $802.0M | $765.0M | $941.0M |
| Interest Expense | $122.0M | $114.0M | $96.00M | $105.0M | $111.0M | $113.0M | $110.0M | $121.0M |
| Income Before Tax | $752.0M | $693.0M | $505.0M | $821.0M | $643.0M | $613.0M | $692.0M | $834.0M |
| Income Tax Expense | $129.0M | $119.0M | $94.00M | $219.0M | $179.0M | $113.0M | $104.0M | $96.00M |
| **Net Income** | $615.0M | $561.0M | $389.0M | $589.0M | $446.0M | $486.0M | $564.0M | $721.0M |
| Basic EPS | $1.36 | $1.24 | $0.85 | -- | $0.98 | $1.06 | $1.23 | -- |
| **Diluted EPS** | $1.36 | $1.24 | $0.85 | -- | $0.98 | $1.06 | $1.23 | -- |
| Basic Shares Outstanding | 452.0M | 453.0M | 456.0M | -- | 456.0M | 457.0M | 457.0M | -- |
| Diluted Shares Outstanding | 453.0M | 454.0M | 457.0M | -- | 457.0M | 458.0M | 459.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.49B | $2.87B | $2.49B | $1.44B |
| **Cash & Short-Term Investments** | $4.49B | $2.87B | $2.49B | $1.44B |
| Inventory | $2.23B | $1.94B | $1.96B | $2.15B |
| Other Current Assets | $726.0M | $532.0M | $389.0M | $417.0M |
| **Total Current Assets** | $12.50B | $9.90B | $9.41B | $8.32B |
| Property, Plant & Equipment, Net | -- | -- | $2.14B | $2.00B |
| Goodwill | $13.49B | $13.14B | $12.94B | $12.81B |
| Intangible Assets | $1.13B | $1.08B | $1.25B | $1.52B |
| Long-Term Investments | $351.0M | $373.0M | $357.0M | $322.0M |
| Other Non-Current Assets | $2.21B | $1.95B | $1.88B | $1.02B |
| **Total Non-Current Assets** | $24.41B | $23.19B | $23.04B | $19.22B |
| **Total Assets** | $36.91B | $33.09B | $32.45B | $27.54B |
| Accounts Payable | $3.25B | $3.04B | $2.95B | $2.94B |
| Short-Term Debt | $1.01B | $3.00B | $2.01B | $22.00M |
| Deferred Revenue (Current) | $2.10B | $1.94B | $1.92B | $1.90B |
| Other Current Liabilities | $1.59B | $1.55B | -- | $2.19B |
| **Total Current Liabilities** | $9.11B | $9.55B | $8.98B | $7.19B |
| Long-Term Debt | $9.49B | $7.45B | $8.44B | $8.23B |
| Deferred Revenue (Non-Current) | $803.0M | $686.0M | $705.0M | $630.0M |
| Other Non-Current Liabilities | $2.06B | $1.80B | $1.88B | $1.60B |
| **Total Non-Current Liabilities** | $17.20B | $14.88B | $16.16B | $10.76B |
| **Total Liabilities** | $26.31B | $24.44B | $25.14B | $17.95B |
| **Total Debt (incl. Leases)** | $10.97B | $10.88B | $10.87B | $8.64B |
| Common Stock | $5.00M | $5.00M | $5.00M | $0 |
| Retained Earnings | $5.28B | $3.26B | $1.33B | $0 |
| Accumulated Other Comp. Income | -$1.39B | -$1.38B | -$691.0M | -$1.88B |
| **Total Stockholders' Equity** | $10.38B | $8.45B | $7.13B | $9.36B |
| Total Equity | $10.39B | $8.46B | $7.14B | $9.36B |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.83B | $2.08B | $2.26B | $4.49B | $4.00B | $3.74B | $2.45B | $2.87B |
| **Cash & Short-Term Investments** | $2.83B | $2.08B | $2.26B | $4.49B | $4.00B | $3.74B | $2.45B | $2.87B |
| Inventory | $2.63B | $2.48B | $2.35B | $2.23B | $2.30B | $2.28B | $2.16B | $1.94B |
| Other Current Assets | $723.0M | $793.0M | $842.0M | $726.0M | $702.0M | $638.0M | $601.0M | $532.0M |
| **Total Current Assets** | $11.49B | $10.50B | $10.43B | $12.50B | $11.89B | $11.31B | $9.73B | $9.90B |
| Goodwill | $15.14B | $15.10B | $15.06B | $13.49B | $13.44B | $13.42B | $13.37B | $13.14B |
| Intangible Assets | $1.81B | $1.89B | $1.91B | $1.13B | $1.16B | $1.22B | $1.24B | $1.08B |
| Long-Term Investments | $383.0M | $362.0M | $352.0M | $351.0M | $302.0M | $244.0M | $235.0M | $373.0M |
| Other Non-Current Assets | $2.28B | $2.25B | $2.25B | $2.21B | $2.15B | $2.08B | $1.93B | $1.95B |
| **Total Non-Current Assets** | $26.88B | $26.75B | $26.70B | $24.41B | $24.23B | $24.19B | $23.85B | $23.19B |
| **Total Assets** | $38.37B | $37.25B | $37.12B | $36.91B | $36.13B | $35.50B | $33.59B | $33.09B |
| Accounts Payable | $3.32B | $3.23B | $3.41B | $3.25B | $2.99B | $2.98B | $3.15B | $3.04B |
| Short-Term Debt | $5.00M | $4.00M | $9.00M | $1.01B | $4.01B | $4.01B | $4.00B | $3.00B |
| Deferred Revenue (Current) | $2.25B | $2.20B | $2.15B | $2.10B | $2.00B | $1.98B | $1.89B | $1.94B |
| Other Current Liabilities | $1.61B | $1.43B | $1.54B | $1.59B | $1.54B | $1.43B | $1.58B | $1.55B |
| **Total Current Liabilities** | $8.81B | $8.30B | $8.53B | $9.11B | $10.07B | $9.75B | $9.97B | $9.55B |
| Long-Term Debt | $9.97B | $10.09B | $10.13B | $9.49B | $8.28B | $8.27B | $6.76B | $7.45B |
| Deferred Revenue (Non-Current) | $895.0M | $857.0M | $819.0M | $803.0M | $775.0M | $741.0M | $724.0M | $686.0M |
| Other Non-Current Liabilities | $2.30B | $2.13B | $2.02B | $2.06B | $2.10B | $2.00B | $1.84B | $1.80B |
| **Total Non-Current Liabilities** | $17.69B | $17.73B | $17.70B | $17.20B | $15.83B | $15.80B | $14.20B | $14.88B |
| **Total Liabilities** | $26.51B | $26.03B | $26.23B | $26.31B | $25.91B | $25.55B | $24.17B | $24.44B |
| **Total Debt (incl. Leases)** | $10.41B | $10.54B | $10.58B | $10.97B | $12.75B | $12.72B | $11.19B | $10.88B |
| Common Stock | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M |
| Retained Earnings | $6.79B | $6.20B | $5.65B | $5.28B | $4.71B | $4.29B | $3.81B | $3.26B |
| Accumulated Other Comp. Income | -$1.46B | -$1.48B | -$1.40B | -$1.39B | -$1.16B | -$1.09B | -$1.20B | -$1.38B |
| **Total Stockholders' Equity** | $11.61B | $10.97B | $10.67B | $10.38B | $9.99B | $9.71B | $9.19B | $8.45B |
| Total Equity | $11.63B | $10.99B | $10.68B | $10.39B | $10.02B | $9.73B | $9.21B | $8.46B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | $2.15B | $2.05B | $1.61B | $1.97B | $2.29B |
| Depreciation & Amortization | $578.0M | $580.0M | $610.0M | $633.0M | $625.0M |
| Stock-Based Compensation | $130.0M | $125.0M | $114.0M | $67.00M | $76.00M |
| Change in Inventory | -$142.0M | -$81.00M | $111.0M | -$402.0M | -$435.0M |
| Change in Payables | $90.00M | $60.00M | -$100.0M | $481.0M | $263.0M |
| **Operating Cash Flow** | $1.99B | $1.96B | $2.10B | $2.13B | $1.61B |
| Capital Expenditure | -$482.0M | -$401.0M | -$387.0M | -$310.0M | -$248.0M |
| **Free Cash Flow** | $1.50B | $1.55B | $1.71B | $1.82B | $1.36B |
| Acquisitions, Net | -$378.0M | -$313.0M | -$147.0M | $0 | -$1.48B |
| Purchases of Investments | -$118.0M | -$40.00M | -$48.00M | -$59.00M | -- |
| **Investing Cash Flow** | -$1.05B | -$914.0M | -$558.0M | -$398.0M | -$1.76B |
| Share Repurchases | -$200.0M | $0 | $0 | -- | -- |
| Dividends Paid | -$64.00M | -$55.00M | -$41.00M | $0 | $0 |
| **Financing Cash Flow** | $617.0M | -$573.0M | -$478.0M | -$822.0M | -$263.0M |
| **Net Change in Cash** | $1.62B | $387.0M | $1.05B | $890.0M | -$451.0M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $623.0M | $573.0M | $411.0M | $602.0M | $464.0M | $500.0M | $588.0M | $738.0M |
| Depreciation & Amortization | $163.0M | $160.0M | $153.0M | $146.0M | $149.0M | $148.0M | $136.0M | $140.0M |
| Stock-Based Compensation | $36.00M | $45.00M | $35.00M | $36.00M | $38.00M | $34.00M | $22.00M | $33.00M |
| Change in Inventory | -$120.0M | -$139.0M | -$171.0M | $75.00M | -$29.00M | -$34.00M | -$154.0M | $76.00M |
| Change in Payables | $61.00M | -$200.0M | $221.0M | $209.0M | -$6.00M | -$259.0M | $146.0M | $127.0M |
| **Operating Cash Flow** | $907.0M | $168.0M | $290.0M | -- | $593.0M | $94.00M | $250.0M | -- |
| Capital Expenditure | -$114.0M | -$100.0M | -$178.0M | -$134.0M | -$110.0M | -$86.00M | -$152.0M | -$102.0M |
| **Free Cash Flow** | $793.0M | $68.00M | $112.0M | -- | $483.0M | $8.00M | $98.00M | -- |
| Acquisitions, Net | $0 | $4.00M | -$2.30B | -$99.00M | $0 | -$10.00M | -$269.0M | -$54.00M |
| Purchases of Investments | -$33.00M | -$6.00M | -$13.00M | -$36.00M | -$54.00M | -$8.00M | -$20.00M | -$7.00M |
| **Investing Cash Flow** | -$111.0M | -$115.0M | -$2.50B | -$269.0M | -$148.0M | -$223.0M | -$407.0M | -$240.0M |
| Share Repurchases | $0 | -$200.0M | -$100.0M | $0 | -$100.0M | -$100.0M | $0 | -- |
| Dividends Paid | -$16.00M | -$16.00M | -$16.00M | -$16.00M | -$16.00M | -$16.00M | -$16.00M | -$14.00M |
| **Financing Cash Flow** | -$40.00M | -$236.0M | $21.00M | -$293.0M | -$165.0M | $1.36B | -$286.0M | -$1.28B |
| **Net Change in Cash** | $749.0M | -$180.0M | -$2.23B | $486.0M | $264.0M | $1.29B | -$416.0M | -$679.0M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 40.0% | 41.7% | 40.5% | 39.1% | 40.8% |
| **Operating Margin** | 13.4% | 13.3% | 12.5% | 13.8% | 15.9% |
| **Net Profit Margin** | 10.1% | 10.1% | 8.0% | 10.4% | 12.8% |
| Return on Equity (ROE) | 20.1% | 23.6% | 22.0% | 20.5% | -- |
| Return on Assets (ROA) | 5.6% | 6.0% | 4.8% | 7.0% | -- |
| Current Ratio | 1.37x | 1.04x | 1.05x | 1.16x | -- |
| Quick Ratio | 1.13x | 0.83x | 0.83x | 0.86x | -- |
| Debt to Equity | 1.06x | 1.29x | 1.52x | 0.92x | -- |
| **Revenue Growth (YoY)** | +4.8% | +0.6% | +6.6% | +4.3% | -- |
| Gross Profit Growth (YoY) | +0.5% | +3.6% | +10.3% | +0.1% | -- |
| Operating Income Growth (YoY) | +5.3% | +7.8% | -3.4% | -9.8% | -- |
| **Net Income Growth (YoY)** | +4.6% | +27.1% | -18.2% | -14.7% | -- |
| EPS Growth (YoY) | +4.3% | +43.3% | -27.7% | -14.7% | -- |
| Operating Cash Flow Growth (YoY) | +1.6% | -6.9% | -1.5% | +32.8% | -- |
| Free Cash Flow Growth (YoY) | -3.2% | -9.3% | -6.0% | +34.2% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 39.9% | 39.5% | 39.1% | 40.0% | 40.8% | 41.6% | 42.0% | 41.7% |
| **Operating Margin** | 13.3% | 12.9% | 12.6% | 13.4% | 13.5% | 13.8% | 13.7% | 13.3% |
| **Net Profit Margin** | 10.0% | 9.3% | 9.1% | 10.1% | 11.0% | 11.2% | 11.0% | 10.1% |
| Return on Equity (ROE) | 18.5% | 18.1% | 17.9% | 20.1% | 22.2% | 23.1% | 23.8% | 23.6% |
| Return on Assets (ROA) | 5.6% | 5.3% | 5.1% | 5.6% | 6.1% | 6.3% | 6.5% | 6.0% |
| Current Ratio | 1.30x | 1.26x | 1.22x | 1.37x | 1.18x | 1.16x | 0.98x | 1.04x |
| Quick Ratio | 1.01x | 0.97x | 0.95x | 1.13x | 0.95x | 0.93x | 0.76x | 0.83x |
| Debt to Equity | 0.90x | 0.96x | 0.99x | 1.06x | 1.28x | 1.31x | 1.22x | 1.29x |
| **Revenue Growth (YoY)** | +7.2% | +5.8% | +7.4% | +7.1% | +5.8% | +3.5% | +2.7% | +2.2% |
| Gross Profit Growth (YoY) | +11.8% | +9.8% | -1.7% | -0.6% | -1.8% | -0.8% | +5.8% | +5.5% |
| Operating Income Growth (YoY) | +23.3% | +13.0% | -18.1% | +3.2% | -3.4% | +7.6% | +16.5% | +16.3% |
| **Net Income Growth (YoY)** | +37.9% | +15.4% | -31.0% | -18.3% | -5.1% | +13.6% | +50.8% | +78.9% |
| EPS Growth (YoY) | +38.8% | +17.0% | -30.9% | -- | -4.9% | +12.8% | +50.0% | -- |
| Operating Cash Flow Growth (YoY) | +53.0% | +78.7% | +16.0% | -- | -- | -- | -40.3% | -- |
| Free Cash Flow Growth (YoY) | +64.2% | +750.0% | +14.3% | -- | -- | -- | -64.2% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
